Renal Medullary Carcinoma — Trials

Renal Medullary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02875548	A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study(TRuST)	completed	Phase 1 / Phase 2	58	Epizyme, Inc.INDUSTRY	7	Nov 4, 2025	clinicaltrials
NCT04537715	Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels	completed	Phase 1	42	Epizyme, Inc.INDUSTRY	2	Feb 19, 2025	clinicaltrials